- Reaction score
- 0
- Points
- 210
VNS Therapy is a non-drug treatment option that offers a unique safety profile and mechanism of action. Approved for use in treatment-resistant epilepsy and in treatment-resistant depression, VNS Therapy delivers long-term benefits to patients who have not responded well to other treatment options.
VNS (vagus nerve stimulation) Therapy is a unique treatment approach now available specifically for treatment-resistant depression. VNS Therapy is indicated for use as an adjunctive long-term treatment of chronic or recurrent depression for patients 18 years of age or older who are experiencing a major depressive episode and have not had an adequate response to four or more adequate antidepressant treatments.
http://www.vnstherapy.com/depression/main.asp
Le « pacemaker » du cerveau
Après le coeur, le cerveau. Une équipe de psychiatres et de neurochirurgiens du Centre hospitalier universitaire de Montréal tente d'implanter une technique de neurostimulation chez des patients dépressifs
http://www.radio-canada.ca/emissions/decouverte/2008-2009/Reportage.asp?idDoc=78474&autoPlay=http://www.radio-canada.ca/Medianet/2009/CBFT/Decouverte200904121830_1.asx
The product is licensed in Canada for use in Epilepsy and depression. HC License # 52. You can search for the license on the Health Canada website at the following link.
http://webprod.hc-sc.gc.ca/mdll-limh/prepareSearch-preparerRecherche.do?type
VNS (vagus nerve stimulation) Therapy is a unique treatment approach now available specifically for treatment-resistant depression. VNS Therapy is indicated for use as an adjunctive long-term treatment of chronic or recurrent depression for patients 18 years of age or older who are experiencing a major depressive episode and have not had an adequate response to four or more adequate antidepressant treatments.
http://www.vnstherapy.com/depression/main.asp
Le « pacemaker » du cerveau
Après le coeur, le cerveau. Une équipe de psychiatres et de neurochirurgiens du Centre hospitalier universitaire de Montréal tente d'implanter une technique de neurostimulation chez des patients dépressifs
http://www.radio-canada.ca/emissions/decouverte/2008-2009/Reportage.asp?idDoc=78474&autoPlay=http://www.radio-canada.ca/Medianet/2009/CBFT/Decouverte200904121830_1.asx
The product is licensed in Canada for use in Epilepsy and depression. HC License # 52. You can search for the license on the Health Canada website at the following link.
http://webprod.hc-sc.gc.ca/mdll-limh/prepareSearch-preparerRecherche.do?type
